The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro (obinutuzumab) as a treatment for lupus nephritis, with a decision expected in ...

GSK estimates that around 60% of the 300,000-plus severe SLE patients in the US suffer from lupus nephritis each year, and a quarter of those develop end-stage renal disease.

Recently, ‘Liquid crystal display (LCD) vs. organic light-emitting diode (OLED) display: who wins?’ has become a topic of heated debate. In this review, we perform a systematic and comparative ...

A total of 1522 guests have reviewed Symphony of the Seas, giving it a rating of 4.6 on a scale of 1-5. Ok trip The cruise was what we expected, we had been to the stops before. Like that we did ...